Overview

Regenerative Medicine Market is poised to value USD 27867.84 million by 2028 end at a CAGR of 15.9% during the forecast period 2022 to 2028.

A growing emphasis on stem cells and increasing research and development activities in developing nations are predicted to boost the global market growth. The emerging economies are focused on advancements in technology, which is predicted to propel market proliferation worldwide. Although, high treatment costs using regenerative medicine, strict regulations by the government and inefficiency in various operations and are projected to impede the market growth.

The dermatology segment dominated the dominate with respect to the generation of revenue in 2018. This subjugation can be credited to this largest global regenerative medicine market share that includes the easy availability of grafting methods for treating skin wounds and diseases. A substantial number of Food and Drug Administration (FDA) approved products for healing wounds are available for clinical applications over the last ten years.

Additionally, different advanced approaches in initial phases of development endorse tissue engineering. This includes the usage of drug delivery systems and biomaterials, which influence the replication of cells and control and stimulate the immune system. Increased complications of the process of wound healing with adverse diseases, for instance, HIV and diabetes have motivated research and development activities assisting the segment growth.

Major players equipped with novel technologies provide manufacturing, management, engineering, quality control services and characterization along with other facilities for researches related to the development of therapies of regeneration and clinical trials. Therefore, with a rise in clinical trials and research and development activities of regenerative medicines, the services segment is predicted to exhibit growth at a soaring rate.

Key market players included in the global regenerative medicine industry are:

• Acelity Holdings, Inc.
• Athersys, Inc.
• Cryolife, Inc.
• Integra Lifesciences Corporation
• Isto Biologics
• Medtronic Plc.
• Organogenesis Inc.
• Stryker Corporation
• U.S. Stem Cell, Inc.
• Zimmer Biomet Holdings, Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Regenerative Medicine Market Segmentation:

By Product Type

• Cell Therapy
• Gene Therapy
• Tissue Engineering
• Small Molecule & Biologic

By Material

• Synthetic Material
o Biodegradable Synthetic Polymer
o Scaffold
o Artificial Vascular Graft Material
o Hydrogel Material
• Biologically Derived Material
o Collagen
o Xenogeneic Material
• Genetically Engineered Material
o Deoxyribonucleic Acid Transfection Vector
o Genetically Manipulated Cell
o Three-Dimensional Polymer Technology
o Transgenic
o Fibroblast
o Neural Stem Cell
o Gene-Activated Matrices
• Pharmaceuticals
o Small Molecule
o Biologic

By Application

• Cardiovascular
• Oncology
• Dermatology
• Musculoskeletal
• Wound Healing
• Ophthalmology
• Neurology
• Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global regenerative medicine market by product type, by material, by application and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com